Experimental Whole-Virus Flu Vaccine Shows Safety and Broad Immune Signals in First Human Trial
A phase 1 trial found that the BPL-1357 whole-virus inactivated influenza vaccine was well tolerated and induced broad antibody responses ...
A phase 1 trial found that the BPL-1357 whole-virus inactivated influenza vaccine was well tolerated and induced broad antibody responses ...
A two-season analysis of the UK's FluSurvey platform shows most influenza-like illness never reaches healthcare services, yet volunteer-reported symptoms closely ...
Cryo-EM and binding assays reveal that hemagglutinin mutations E190D and Q226H in H5N1 viruses from a severely ill British Columbia ...
A new diffusion-model-based tool called Influpaint encodes influenza seasons as spatiotemporal images and generates competitive, probabilistic forecasts of epidemic trajectories ...
Deep mutational scanning of the CR9114 antibody reveals that epistasis and pleiotropy make cross-reactive breadth against both influenza A and ...
An international expert panel coordinated by West China Hospital has published twelve consensus recommendations to prevent secondary mucormycosis following respiratory ...
Molecular dynamics simulations show that thyme constituents, especially thymol, bind and structurally destabilize influenza H1N1 hemagglutinin more effectively than curcumin.
A three-year surveillance study of 1,716 patients in Kaifeng, China, maps the local respiratory pathogen spectrum and finds that most ...
New research identifies endothelial Angptl2 as a key molecular driver linking influenza-induced vascular injury to pulmonary fibrosis through EndMT and ...
A cross-sectional survey of 547 Chinese outpatients with chronic diseases found that only 19.6 percent received annual influenza vaccination, with ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine